Suchergebnisse - "Kovanen, Petri T"

PubPharm (293)

41

Hydroxychloroquine reduces interleukin-6 levels after myocardial infarction : The randomized, double-blind, placebo-controlled OXI pilot trial

enthalten in: International journal of cardiology | 2021

von Ulander, L. | Tolppanen, H. | Hartman, O. | +18

42

Coronary artery disease : 'gout' in the artery?

enthalten in: European heart journal | 2021

von Strandberg, T. | Kovanen, P.

43

Comment on : "Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry"

enthalten in: Drugs | 2021

von Vuorio, A. | Kovanen, P.

CommentOn: Drugs. 2021 Apr;81(6):685-695. - PMID 33782908

44

Familial hypercholesterolemia and statins in the COVID-19 era : Mitigating the risk of ischemic stroke

enthalten in: eNeurologicalSci | 2021

von Vuorio, A. | Kaste, M. | Kovanen, P.

45

Lysophosphatidylcholine in phospholipase A2-modified LDL triggers secretion of angiopoietin 2

enthalten in: Atherosclerosis | 2021

von Nguyen, S. | Korhonen, E. | Lorey, M. | +6

46

The homeoviscous adaptation to dietary lipids (HADL) hypothesis is probably incorrect

enthalten in: The American journal of clinical nutrition | 2021

von Christensen, J. | Telle-Hansen, V. | Ulven, S. | +4

CommentOn: Am J Clin Nutr. 2021 Feb 2;113(2):277-289. - PMID 33471045

47

Comment on: “Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry”

enthalten in: Drugs | 2021

von Vuorio, A. | Kovanen, P.

48

Comment on: “Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry”

enthalten in: Drugs | 2021

von Vuorio, A. | Kovanen, P.

49

A tale of two therapies lipid-lowering vs. anti-inflammatory therapy : a false dichotomy?

enthalten in: European heart journal. Cardiovascular pharmacotherapy | 2021

von Strandberg, T. | Libby, P. | Kovanen, P.

50

Aggregation Susceptibility of Low-Density Lipoproteins-A Novel Modifiable Biomarker of Cardiovascular Risk

enthalten in: Journal of clinical medicine | 2021

von Öörni, K. | Kovanen, P.